Mary B Dratman - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Mary B Dratman

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

AIMS Neuroscience|May 27, 2020

The many faces of thyroxineMary B Dratman, Joseph V Martin

Synapse (New York, N.Y.)|June 2, 2006

Imaging triiodothyronine binding kinetics in rat brain: a model for studies in human subjectsJoel H Greenberg, Martin Reivich, Janice T Gordon, et al.

Brain Research|July 10, 2010

3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulatorHeinrich S Gompf, Joel H Greenberg, Gary Aston-Jones, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

AIMS Neuroscience|May 27, 2020

The many faces of thyroxineMary B Dratman, Joseph V Martin

Synapse (New York, N.Y.)|June 2, 2006

Imaging triiodothyronine binding kinetics in rat brain: a model for studies in human subjectsJoel H Greenberg, Martin Reivich, Janice T Gordon, et al.

Brain Research|July 10, 2010

3-Monoiodothyronamine: the rationale for its action as an endogenous adrenergic-blocking neuromodulatorHeinrich S Gompf, Joel H Greenberg, Gary Aston-Jones, et al.

Pageof 1